Literature DB >> 8099141

Intestinal permeability and the prediction of relapse in Crohn's disease.

J Wyatt1, H Vogelsang, W Hübl, T Waldhöer, H Lochs.   

Abstract

To see whether intestinal permeability (IP) predicted relapse in Crohn's disease, we measured IP in 72 patients with quiescent Crohn's disease using the lactulose-mannitol test. The permeability index (lactulose/mannitol) was significantly higher in patients than in controls (0.046 [SEM 0.005] vs 0.018 [SEM 0.002], respectively). Patients were followed for 1 year after the test. 26 of the 37 patients with raised permeability, but only 6 of the 35 with normal permeability relapsed within 1 year after the test (p < 0.001). The sensitivity of the permeability test as a predictor for relapse was 81%. A significant correlation was found between the value of the permeability index and the probability of relapse (p < 0.01). These results show that increases in intestinal permeability precede clinical relapses in Crohn's disease and so are an indicator of subclinical disease. The measurement of intestinal permeability may lead to a better understanding of the pathogenesis of Crohn's disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8099141     DOI: 10.1016/0140-6736(93)90882-h

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  190 in total

1.  Mesenteric blood flow is related to disease activity and risk of relapse in ulcerative colitis: a prospective follow up study.

Authors:  D Ludwig; S Wiener; A Brüning; K Schwarting; G Jantschek; K Fellermann; M Stahl; E F Stange
Journal:  Gut       Date:  1999-10       Impact factor: 23.059

Review 2.  Evaluation of inflammatory activity in Crohn's disease and ulcerative colitis.

Authors:  Eduardo Garcia Vilela; Henrique Osvaldo da Gama Torres; Fabiana Paiva Martins; Maria de Lourdes de Abreu Ferrari; Marcella Menezes Andrade; Aloísio Sales da Cunha
Journal:  World J Gastroenterol       Date:  2012-03-07       Impact factor: 5.742

3.  Histopathological parameters as predictors for the course of Crohn's disease.

Authors:  Frauke Bataille; Frank Klebl; Petra Rümmele; Rainer H Straub; Peter Wild; Jürgen Schölmerich; Ferdinand Hofstädter
Journal:  Virchows Arch       Date:  2003-07-24       Impact factor: 4.064

4.  The JAK2 variant rs10758669 in Crohn's disease: altering the intestinal barrier as one mechanism of action.

Authors:  Matthias Prager; Janine Büttner; Verena Haas; Daniel C Baumgart; Andreas Sturm; Martin Zeitz; Carsten Büning
Journal:  Int J Colorectal Dis       Date:  2011-11-09       Impact factor: 2.571

Review 5.  Myosin light chain kinase: pulling the strings of epithelial tight junction function.

Authors:  Kevin E Cunningham; Jerrold R Turner
Journal:  Ann N Y Acad Sci       Date:  2012-07       Impact factor: 5.691

Review 6.  Tight junctions on the move: molecular mechanisms for epithelial barrier regulation.

Authors:  Le Shen
Journal:  Ann N Y Acad Sci       Date:  2012-07       Impact factor: 5.691

Review 7.  Tight junction pore and leak pathways: a dynamic duo.

Authors:  Le Shen; Christopher R Weber; David R Raleigh; Dan Yu; Jerrold R Turner
Journal:  Annu Rev Physiol       Date:  2011       Impact factor: 19.318

8.  CCR6 regulation of the actin cytoskeleton orchestrates human beta defensin-2- and CCL20-mediated restitution of colonic epithelial cells.

Authors:  Rebecca A Vongsa; Noah P Zimmerman; Michael B Dwinell
Journal:  J Biol Chem       Date:  2009-02-20       Impact factor: 5.157

9.  LIGHT signals directly to intestinal epithelia to cause barrier dysfunction via cytoskeletal and endocytic mechanisms.

Authors:  Brad T Schwarz; Fengjun Wang; Le Shen; Daniel R Clayburgh; Liping Su; Yingmin Wang; Yang-Xin Fu; Jerrold R Turner
Journal:  Gastroenterology       Date:  2007-02-27       Impact factor: 22.682

10.  Enterococcus faecalis Gelatinase Mediates Intestinal Permeability via Protease-Activated Receptor 2.

Authors:  Nitsan Maharshak; Eun Young Huh; Chorlada Paiboonrungruang; Michael Shanahan; Lance Thurlow; Jeremy Herzog; Zorka Djukic; Roy Orlando; Rafal Pawlinski; Melissa Ellermann; Luke Borst; Siten Patel; Iris Dotan; Ryan B Sartor; Ian M Carroll
Journal:  Infect Immun       Date:  2015-04-27       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.